RedHill Biopharma Reports Second Quarter 2021 Financial Results and Operational Highlights

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/6/2026

1. KRG
2. ALAR
3. FFAI
4. SPY
5. SKA-B
6. BAF:IN
7. PBA
8. CIFC:IN
9. APTX:CN
10. CCH:LN

Go back to RedHill Biopharma Reports Second Quarter 2021 Financial Results and Operational Highlights

RedHill Biopharma (RDHL) Tops Q2 EPS by 6c, Revenue Misses Consensus

August 26, 2021 7:10 AM EDT

RedHill Biopharma (NASDAQ: RDHL) reported Q2 EPS of ($0.06), $0.06 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $21.5 million versus the consensus estimate of $25.02 million.

For earnings history and earnings-related data on RedHill Biopharma (RDHL) click here.

... More